SCHEMBL25974137

SCHEMBL25974137

Oc1ccc(-c2cccnc2Nc2ccc(C(F)(F)F)cc2)cc1C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 13/20 0.49
▸ EPHX2 P34913 6/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25974136 0.88 EPHX2 (0.48) TRPV1EPHX2
SCHEMBL25974054 0.84 TRPV1 (0.44) TRPV1EPHX2
SCHEMBL25974213 0.83 TRPV1 (0.51) TRPV1EPHX2
SCHEMBL25339100 0.81 LMNA (0.43) TRPV1EPHX2
SCHEMBL25974055 0.81 EPHX2 (0.46) TRPV1EPHX2
SCHEMBL30482552 0.78 EGFR (0.47) TRPV1EPHX2
SCHEMBL26202876 0.78 EGFR (0.47) TRPV1EPHX2
SCHEMBL25376256 0.78 KCNQ3 (0.48) TRPV1EPHX2
SCHEMBL21497150 0.78 EPHX2 (0.56) TRPV1EPHX2
SCHEMBL25341064 0.77 TRPV1 (0.50) TRPV1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146513-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback